Pfizer (PFE) Finished Goods (2009 - 2019)

Pfizer (PFE) has 11 years of Finished Goods data on file, last reported at $2.3 billion in Q1 2019.

• Quarterly Finished Goods fell 19.42% year-over-year to $2.3 billion in Q1 2019, while the trailing twelve-month figure through Mar 2019 was $2.3 billion (down 19.42% YoY) and the FY2018 annual result came in at $2.3 billion, down 21.54% from the prior year.
• Finished Goods rose to $2.3 billion in Q1 2019 per PFE's latest filing, from $2.3 billion in the prior quarter.
• Across five years, Finished Goods topped out at $2.9 billion in Q4 2017 and bottomed at $1.8 billion in Q2 2015.
• The 5-year median for Finished Goods is $2.6 billion (2016), against an average of $2.5 billion.
• The widest annual swing landed in 2015, when Finished Goods fell 24.86%; it then soared 49.89% in 2016.
• Tracing PFE's Finished Goods over 5 years: stood at $2.7 billion in 2015, then declined by 15.51% to $2.3 billion in 2016, then climbed by 25.73% to $2.9 billion in 2017, then retreated by 21.54% to $2.3 billion in 2018, then increased by 1.11% to $2.3 billion in 2019.
• Per Business Quant, the three latest PFE Finished Goods figures stand at $2.3 billion (Q1 2019), $2.3 billion (Q4 2018), and $2.6 billion (Q3 2018).

Peer Comparison